RC Kho, M Al-Obailan… - Journal of Neuro- …, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > Current ... Related articles - All 4 versions
C Plinke, K Walter, S Aly, S Ehlers… - Antimicrobial Agents …, 2011 - Am Soc Microbiol Ethambutol (EMB) is a major component of the first-line therapy of tuberculosis. Mutations in codon 306 of embB (embB306) were suggested as a major resistance mechanism in clinical isolates. To directly analyze the impact of individual embB306 mutations on EMB ... Related articles - All 2 versions
CU Koser, DK Summers… - Antimicrobial Agents and …, 2011 - Am Soc Microbiol We thank Goude et al. for their extensive study of the role of embC (Rv3793) in ethambutol (EMB) resistance in Myco- bacterium tuberculosis (9). Their finding that the Thr270Ile change on its own plays no role in EMB resistance is of par- ticular importance (9). Clinical ... Related articles - All 2 versions
JHE Grosset, M Zhang, SY Li… - American Journal of …, 2011 - Am Thoracic Soc Johns Hopkins University, Baltimore, MD, Ecole Polytechnique de Lausanne, Lausanne, Switzerland, University of Florida, Gaineville, FL, 1 2 ... Johns Hopkins University School of Medicine, Baltimore, MD 4 ... Rationale: In mice with there is antagonism between ... All 3 versions
[PDF] from page-meeting.orgS Jonsson, A Davidse, J Wilkins… - Antimicrobial Agents …, 2011 - Am Soc Microbiol Page 1. 1(20) Title: Population pharmacokinetics of ethambutol in South African tuberculosis patients 1 2 Running title: Population pharmacokinetics of ethambutol 3 4 Authors: Siv Jönsson2*, Alistair Davidse1, Justin Wilkins1,2†, Jan-Stefan Van der Walt1,2, 5 ... All 4 versions